Skip to main content
. 2016 Jul 15;36(3):1233–1242. doi: 10.3892/or.2016.4944

Table I.

Expression of apoptosis-related proteins in the treated groups.

Apoptosis-related proteins SKM-1
KG1a
CUR/control (fold-change) ATO/control (fold-change) CUR+ATO/control (fold-change) CUR/control (fold-change) ATO/control (fold-change) CUR+ATO/control (fold-change)
bad 1.141 1.741 2.044a 1.224 0.951 0.854
bax 1.036 1.321 1.375 0.989 1.586 1.970a
bcl-2 0.996 2.094 2.304a 0.775 1.895 0.428b
bcl-w 1.083 1.892 2.098a 0.852 1.907 0.667b
BID 0.739 0.272 0.543b 0.934 1.254 1.138
BIM 1.146 2.071 2.389a 0.883 0.962 0.843
caspase3 1.172 2.280 2.616a 1.125 1.967 2.812a
caspase8 1.118 2.952 3.118a 1.157 1.075 1.152
CD40 0.930 1.534 1.634a 0.789 0.870 0.771
CD40L 1.081 1.803 1.879a 0.805 0.867 0.816
cIAP-2 0.934 0.491 0.528b 0.664 1.320 0.345b
cytoC 1.011 2.156 2.918a 1.314 1.916 2.848a
DR6 1.063 1.448 1.588a 0.792 0.924 0.822
Fas 1.272 2.407 2.468a 0.878 0.851 0.917
FasL 1.080 1.601 1.694a 0.841 1.026 0.858
HSP27 0.894 1.424 1.297 0.881 1.112 0.905
HSP60 1.084 1.604 1.721a 0.858 0.972 0.899
HSP70 1.350 2.763 2.968a 1.244 1.059 1.171
HTRA 0.664 2.784 2.288a 2.088 1.250 2.874a
IGF-I 0.891 1.187 1.163 0.794 1.068 0.720
IGF-II 1.123 2.707 2.948a 1.009 1.334 1.070
IGFBP-1 0.933 1.241 1.304 0.701 0.912 0.599b
IGFBP-2 0.971 1.223 1.253 0.794 0.978 0.479b
IGFBP-3 1.119 1.769 1.888a 0.749 0.891 0.878
IGFBP-4 0.974 1.980 2.012a 0.782 0.961 0.805
IGFBP-5 1.002 4.794 4.849a 0.810 0.952 0.860
IGFBP-6 1.102 0.811 0.905 0.829 1.042 0.867
IGF-1sR 0.929 1.320 1.340 0.745 0.965 0.880
livin 1.139 43.971 47.444a 0.913 1.102 0.910
p21 1.044 1.664 2.177a 0.921 0.980 0.960
p27 1.200 2.269 2.624a 0.918 1.057 0.950
p53 1.097 2.970 3.364a 0.946 1.081 1.005
SMAC 1.025 0.979 1.069 1.032 1.062 1.523a
Survivin 0.805 2.118 0.360b 0.607 1.805 0.215b
sTNF-R1 1.051 1.492 1.323 0.836 1.152 0.772
sTNF-R2 0.819 1.124 1.042 0.693 0.909 0.733
TNF-α 0.828 1.263 1.393 0.671 1.012 0.723
TNF-β 0.945 1.376 1.531a 0.701 0.902 0.820
TRAILR-1 0.942 0.907 0.996 0.790 1.104 0.855
TRAILR-2 1.008 1.633 1.785a 0.843 1.055 0.872
TRAILR-3 0.955 1.421 1.546a 0.799 1.047 0.848
TRAILR-4 1.074 1.620 1.794a 0.845 1.050 0.909
XIAP 0.896 1.340 0.550b 0.741 1.155 0.403b

SKM-1 and KG1a cells were treated with CUR (10 μM) and ATO (8 μM) alone or in combination for 48 h, followed by detection using a protein array kit. Fold-changes ≤0.667 or ≥1.5 indicated proteins were modulated by these drugs.

a

Upregulated,

b

downregulated.